Karyotypic characterization of human T-cell lines immortalized by Herpesvirus saimiri. 1994

B Troidl, and B Simmer, and H Fickenscher, and I Müller-Fleckenstein, and F Emmrich, and B Fleckenstein, and E Gebhart
Institut f. Humangenetik, Friedrick-Alexander-Universität, Erlangen-Nürnberg, Germany.

Herpesvirus saimiri subgroup-C strains transform non-neoplastic human T lymphocytes in vitro to antigen-independent continuous growth. The karyotypes of 8 of these T-cell lines, derived from peripheral blood or bone marrow, are analyzed here. In general, these lines showed a normal diploid karyotype, although one of them had acquired a clonal chromosomal rearrangement after 21 months in culture. Chromosomally aberrant cell clones were found more frequently in cell lines derived from blood lymphocytes of leukemia patients than in cultures from healthy donors. However, the observed aberrations, some of which were defined in detail using chromosome in situ suppression hybridization (CISS) with chromosome-specific recombinant DNA libraries, did not show any relation between the various cell lines nor to the respective types of leukemia.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002884 Chromosomes, Human, Pair 15 A specific pair of GROUP D CHROMOSOMES of the human chromosome classification. Chromosome 15
D005260 Female Females
D006567 Herpesvirus 2, Saimiriine The type species of RHADINOVIRUS, in the subfamily GAMMAHERPESVIRINAE, isolated from squirrel monkeys. It produces malignant lymphomas (LYMPHOMA, MALIGNANT) in inoculated marmosets or owl monkeys. Herpesvirus 2, Saimirine,Herpesvirus 2 (gamma), Saimirine,Herpesvirus Saimiri,Saimiriine Herpesvirus 2,Saimirine Herpesvirus 2,Herpesvirus Saimirus,Saimiri, Herpesvirus,Saimirus, Herpesvirus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Troidl, and B Simmer, and H Fickenscher, and I Müller-Fleckenstein, and F Emmrich, and B Fleckenstein, and E Gebhart
April 1996, Journal of immunology (Baltimore, Md. : 1950),
B Troidl, and B Simmer, and H Fickenscher, and I Müller-Fleckenstein, and F Emmrich, and B Fleckenstein, and E Gebhart
January 2001, Anticancer research,
B Troidl, and B Simmer, and H Fickenscher, and I Müller-Fleckenstein, and F Emmrich, and B Fleckenstein, and E Gebhart
June 1993, Virology,
B Troidl, and B Simmer, and H Fickenscher, and I Müller-Fleckenstein, and F Emmrich, and B Fleckenstein, and E Gebhart
March 1998, Tissue antigens,
B Troidl, and B Simmer, and H Fickenscher, and I Müller-Fleckenstein, and F Emmrich, and B Fleckenstein, and E Gebhart
February 1995, Immunology today,
B Troidl, and B Simmer, and H Fickenscher, and I Müller-Fleckenstein, and F Emmrich, and B Fleckenstein, and E Gebhart
March 1997, Virology,
B Troidl, and B Simmer, and H Fickenscher, and I Müller-Fleckenstein, and F Emmrich, and B Fleckenstein, and E Gebhart
December 1995, Journal of virology,
B Troidl, and B Simmer, and H Fickenscher, and I Müller-Fleckenstein, and F Emmrich, and B Fleckenstein, and E Gebhart
November 2004, Current protocols in immunology,
B Troidl, and B Simmer, and H Fickenscher, and I Müller-Fleckenstein, and F Emmrich, and B Fleckenstein, and E Gebhart
August 1972, Journal of the National Cancer Institute,
B Troidl, and B Simmer, and H Fickenscher, and I Müller-Fleckenstein, and F Emmrich, and B Fleckenstein, and E Gebhart
April 1992, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!